Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses (Q39779693)

14 September 2017

Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses (English)

1 reference

14 September 2017

1 reference

Richer M

1

1 reference

14 September 2017

Allard S

2

1 reference

14 September 2017

Manseau L

3

1 reference

14 September 2017

Vallée F

4

1 reference

14 September 2017

Pak R

5

1 reference

14 September 2017

LeBel M

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

39

1 reference

14 September 2017

5

1 reference

14 September 2017

1082-1086

1 reference

Pharmacokinetics of tissue penetration of antibiotics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

FK 482, a new orally active cephalosporin synthesis and biological properties

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

The in-vitro activity of cefdinir (FK482), a new oral cephalosporin

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162687

Impairment of cefdinir absorption by iron ion

15 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7625793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro antibacterial activity of FK482, a new orally active cephalosporin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7625793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cefixime, in-vitro activity, pharmacokinetics and tissue penetration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7625793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.39.5.1082

1 reference

14 September 2017

1 reference

14 September 2017

1 reference